With the response to question n. 529 of 6 August 2021, the Inland Revenue expressed its opinion on the VAT treatment of the price adjustments of the goods determined on the basis of the profits achieved by the parties.
In particular, in the case covered by the aforementioned ruling, the Applicant (hereinafter “Alfa”) and “Beta”, companies operating in the pharmaceutical sector, had entered into a contract under which:
- “Alfa” was responsible for the production and development of an active ingredient; And
- “Beta” was responsible for the purchase of the active ingredient from “Alfa”, its transformation into a finished product and the subsequent marketing phase.
Source PwC
References to ECJ Cases
- ECJ Cases C-249/12 (Tulică) & C-250/12 (Plavoşin) – Price is considered is assumed to include VAT in case not mentioned in the agreement
- ECJ Case – C-549/11 – Orfey Balgaria EOOD – Liability before services are provided when all details are known and services are accurately described
- ECJ Cases – C-621/10 & C-129/11 (Balkan and Sea Properties and Provadinvest) – Opting for normal value is not allowed in cases that are not listed in Art. 80 of the VAT Directive
Latest Posts in "Italy"
- 2026 VAT Reform: New Criteria for Taxable Base in Barter Transactions Align with EU Directive
- New Explanatory Notes on ViDA and VAT Reforms Effective from 2027: Key Changes and Implications
- Interest Income and Pro Rata VAT: Supreme Court Clarifies Criteria for Deductibility and Accessory Activities
- Assonime Proposes Amendment to VAT Base Calculation for Barter Transactions Based on Contract Value
- Streamlining Procedures for Recovering Non-Deducted VAT in MLBO Transactions: Assonime’s Analysis
